Cardio Diagnostics Holdings, Inc.
CDIO
$2.07
$0.115.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -25.13% | -16.08% | -57.31% | -55.74% | -50.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.13% | -16.08% | -57.31% | -55.74% | -50.13% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -25.13% | -16.08% | -57.31% | -55.74% | -50.13% |
| SG&A Expenses | -3.42% | 3.30% | -33.13% | -29.11% | -32.63% |
| Depreciation & Amortization | 3.67% | 21.66% | 386.12% | 666.67% | 411.11% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.49% | 13.60% | -22.64% | -22.24% | -26.13% |
| Operating Income | -3.58% | -13.70% | 22.49% | 22.10% | 26.01% |
| Income Before Tax | -3.51% | -13.60% | 22.49% | 20.61% | 28.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.51% | -13.60% | 22.49% | 20.61% | 28.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.51% | -13.60% | 22.49% | 20.61% | 28.76% |
| EBIT | -3.58% | -13.70% | 22.49% | 22.10% | 26.01% |
| EBITDA | -3.94% | -14.75% | 24.77% | 24.44% | 28.75% |
| EPS Basic | 39.58% | 39.36% | 64.68% | 64.80% | 67.15% |
| Normalized Basic EPS | 39.59% | 39.36% | 64.68% | 66.81% | 69.22% |
| EPS Diluted | 39.58% | 39.36% | 64.68% | 64.80% | 67.15% |
| Normalized Diluted EPS | 39.59% | 39.36% | 64.68% | 66.81% | 69.22% |
| Average Basic Shares Outstanding | 68.89% | 78.60% | 95.39% | 123.65% | 123.32% |
| Average Diluted Shares Outstanding | 68.89% | 78.60% | 95.39% | 123.65% | 123.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |